Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo, 113-8655, Japan.
Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo, Tokyo, 113-8655, Japan.
J Reprod Immunol. 2020 Jun;139:103104. doi: 10.1016/j.jri.2020.103104. Epub 2020 Feb 21.
To evaluate the anti-inflammatory and anti-angiogenetic effects of Tokishakuyakusan (TSS), a traditional Japanese medicine (Kampo), and its ingredients, ferulic acid (FA) and paeoniflorin (PA) on endometriotic stromal cells (ESC) and peritoneal macrophages.
Endometriotic tissues were obtained from 16 patients and peritoneal macrophages were obtained from 11 patients that had undergone laparoscopic surgery for ovarian endometriosis. ESC isolated from endometriotic tissues and peritoneal macrophages were cultured, and pre-treated with 300 μg/mL of TSS, 500 μM FA or 50 μM PA. ESC and peritoneal macrophages were then stimulated with IL-1β. Concentrations of IL-8 and VEGF protein in supernatants were then detected and measured using specific ELISAs. TSS (4 g/kg body weight) was orally administered to female Sprague-Dawley rats. The concentration of FA in plasma and uteri was measured using liquid chromatography-mass spectrometry with tandem mass spectrometry (LC-MS/MS). RESULTS: TSS and FA but not PA decreased the secretion of inflammatory cytokine (IL-8) and angiogenic factor (VEGF) in ESC. TSS and FA also suppressed the secretion of inflammatory cytokine (IL-8) from peritoneal macrophages. FA was detected in plasma and in uterine tissues after the oral administration of TSS to rats.
Our study demonstrates that TSS has anti-inflammatory and anti-angiogenic effects on endometriosis related cells by controlling inflammatory cytokine and growth factor secretion from cells, and these effects, at least partially, may be due to the direct effects of the TSS ingredient FA.
评估传统日本药物(汉方药)通仙散(TSS)及其成分阿魏酸(FA)和芍药苷(PA)对子宫内膜异位症基质细胞(ESC)和腹腔巨噬细胞的抗炎和抗血管生成作用。
从 16 名接受腹腔镜卵巢子宫内膜异位症手术的患者中获得子宫内膜异位症组织,并从 11 名患者中获得腹腔巨噬细胞。从子宫内膜异位症组织中分离出 ESC,并培养腹腔巨噬细胞,然后用 300μg/ml 的 TSS、500μM FA 或 50μM PA 预处理。然后用 IL-1β刺激 ESC 和腹腔巨噬细胞。使用特异性 ELISA 检测和测量上清液中 IL-8 和 VEGF 蛋白的浓度。将 TSS(4g/kg 体重)口服给予雌性 Sprague-Dawley 大鼠。使用液相色谱-串联质谱法(LC-MS/MS)测量血浆和子宫中 FA 的浓度。
TSS 和 FA 但不是 PA 降低了 ESC 中炎症细胞因子(IL-8)和血管生成因子(VEGF)的分泌。TSS 和 FA 还抑制了腹腔巨噬细胞中炎症细胞因子(IL-8)的分泌。在大鼠口服 TSS 后,FA 可在血浆和子宫组织中检测到。
我们的研究表明,TSS 通过控制细胞分泌炎症细胞因子和生长因子对与子宫内膜异位症相关的细胞具有抗炎和抗血管生成作用,这些作用至少部分可能是由于 TSS 成分 FA 的直接作用。